To share our experience of presentations and management of metastatic carcinoma prostate and its complications in tertiary care hospital in underdeveloped country.Methods:This is retrospective study conducted in institute of kidney diseases Peshawar from January 2017 to December 2020 .Patients were sampled through non probability randomized method mode of presentation ,diagnosis and management of metastatic carcinoma prostate complications were evaluated and analyzed .Results:There were 80 patients in the study ,63 patients opted for medical castration while in 17 patients bilateral orchidectomies done for androgen blockade . Docetoxil added long with ADT for androgen blockade in 12 patients who were labeled castrate resistant .12 patients present with urinary retention and channel TURP performed on them and 2 patients have hematuria due to mets in urinary bladder and 4 patients have skeletal metastasis and were managed in respective department. Conclusion:This study concludes that in under developed countries like Pakistan mostly patients of carcinoma prostate present in metastatic stage with multiple complications and most of complications can be managed in urology department in close collaboration with other specialized units.
Defective repair of DNA when heterozygous leads to Lynch syndrome (LS) which is inherited in an autosomal dominant fashion. When homozygous, defective repair of DNA leads to constitutional mismatch repair deficiency syndrome (CMMRD), inherited in an autosomal recessive fashion with a predisposition to develop a pattern of childhood malignancies including hematological and solid cancers. We report such a case of a 21-year-old male who developed anaplastic astrocytoma, Burkitt lymphoma, osteochondroma, and colon cancer successively. Each cancer was treated successfully except for colon cancer which developed liver metastasis after the initial treatment with curative intent. However, the patient has been treated for liver metastasis with curative intent and is currently on follow-up. This case report highlights the importance of maintaining a low threshold for investigating CMMRD and other potential cancer predisposition syndromes when a patient presents with multiple cancers in the early years of their life.
To share our experience of presentations and management of metastatic carcinoma prostate and its complications in tertiary care hospital in underdeveloped country.Methods:This is retrospective study conducted in institute of kidney diseases Peshawar from January 2017 to December 2020 .Patients were sampled through non probability randomized method mode of presentation ,diagnosis and management of metastatic carcinoma prostate complications were evaluated and analyzed .Results:There were 80 patients in the study ,63 patients opted for medical castration while in 17 patients bilateral orchidectomies done for androgen blockade . Docetoxil added long with ADT for androgen blockade in 12 patients who were labeled castrate resistant .12 patients present with urinary retention and channel TURP performed on them and 2 patients have hematuria due to mets in urinary bladder and 4 patients have skeletal metastasis and were managed in respective department. Conclusion:This study concludes that in under developed countries like Pakistan mostly patients of carcinoma prostate present in metastatic stage with multiple complications and most of complications can be managed in urology department in close collaboration with other specialized units.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.